1Nordmann P, Cuzon G, Naas T, et al. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria[J]. Lancet Infect Dis, 2009,9(4): 228-236.
2Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem- hydrolyzing beta lactamase, KPC-1, from a carbapenem- resistant strain of Klebsiella pneumoniae [J]. Antimierob Agents Chemother, 2001,45(4) 1151 1161.
3WaltheRasmussen J, Hoiby N. Class A carbapenemases [J]. J Antimicrob Chemother, 2007,60(3) :470-482.
4Pulcrano G, Lula DV, de Luca C, et al. Clonal dissemination of Klebsiella pneumoniae ST512 carrying blaKPC-3 in a hospital in southern Italy [J]. APMIS, 2014,122(1):42 46.
5Coatsworth NR, Huntington PG, Hardiman RP, et al. A case of carbapenemase producing Klebsiella pneumoniae in Australia [J]. Pathology, 2012, 44(1) :42-44.
6Chua KY, Grayson ML, Burgess AN, et al. The growing burden o multidrug resistant infections among returned Australian travellers [J]. Med J Aust, 2014,200(2) . 116 118.
7Cuzon G, Naas T, Demachy MC, et al. Nosocomial outbreak of Klebsiella pneumoniae harbouring blaKpc-3 in France subsequent to a patient transfer from Italy[J]. J Antimicrob Agents, 2012,39(5):448-449.
8Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China [J]. Antimicrob Agents Chemother, 2007, 51(2)763-765.
9Zhu JM, Jiang RJ, Mi ZH, et al. Novel KPC variant from a carbapenem-resistant strain of Klebsiella pneumoniae in a Chinese hospital[J]. Infect Control Hosp Epidemiol, 2011, 32(10) : 1050-1052.
10Hawser SP, Bouchillon SK, Lascols C, et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem- resistant isolates [J]. Antimicrob Agents Chemother, 2011, 55(8) :3917-3921.
